Ticker brief
TARS
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
6
authors 14d
3
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-07-01 → 2026-07-02 · now +0.48 (−1 bearish … +1 bullish)
Who spoke3
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @semodough | C | -0.75 | 4 | +0.48 |
| @OpenOutcrier | C | · | 1 | -0.20 |
| @PersimmonTI | A | -0.32 | 1 | -0.25 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-02 | @semodough | +0.60 | Mizuho model supports larger TARS/Xdemvy opportunity than Culper short report suggests. | · | tweet ↗ |
| 2026-07-02 | @semodough | +0.40 | Reports TARS $9 rebound after short report and nurse comments. | · | tweet ↗ |
| 2026-07-02 | @semodough | +0.45 | Mizuho has PT $100 and stays Outperform after short report attack. | · | tweet ↗ |
| 2026-07-01 | @PersimmonTI | -0.25 | Mentions TARS short report and hints at concerns from PRs, but details absent. | · | tweet ↗ |
| 2026-07-01 | @OpenOutcrier | -0.20 | Recap of positive and negative comments from 7/1. | · | tweet ↗ |
| 2026-07-01 | @semodough | +0.45 | Says TARS biotech launch is becoming very profitable in 2027. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.